We are live on ! Find out more
WCA

Waypoint Capital Advisors Portfolio holdings

AUM $470M
1-Year Est. Return 32.8%
This Fund
S&P 500
This Quarter Est. Return
-4.2%
1 Year Est. Return
+32.8%
3 Year Est. Return
+50.26%
5 Year Est. Return
10 Year Est. Return
AUM
$170M
AUM Growth
+$24.4M
Cap. Flow
+$32.3M
Cap. Flow %
18.99%
Top 10 Hldgs %
42.13%
Holding
125
New
28
Increased
49
Reduced
19
Closed
6

Top Sells

Rank Stock Value
1
VNQ icon
Vanguard Real Estate ETF
VNQ
+$2.22M
2
MMM icon
3M
MMM
+$223K
3
NFLX icon
Netflix
NFLX
+$206K
4
BIBL icon
Inspire 100 ETF
BIBL
+$202K
5
CRM icon
Salesforce
CRM
+$202K

Sector Composition

Rank Sector Weight
1 Technology 15.26%
2 Healthcare 14.67%
3 Industrials 10.06%
4 Consumer Staples 9.17%
5 Consumer Discretionary 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QCOM icon
101
Qualcomm
QCOM
$155B
$261K 0.15%
1,707
+396
+30% +$66.4K
TSLA icon
102
Tesla
TSLA
$1.23T
$249K 0.15%
693
+96
+16% +$29.9K
HPQ icon
103
HP
HPQ
$24.9B
$242K 0.14%
6,658
VTV icon
104
Vanguard Morningstar Value ETF
VTV
$188B
$240K 0.14%
+1,629
New +$238K
HDV
105
iShares Core High Dividend ETF
HDV
$14.5B
$239K 0.14%
11,160
BAX icon
106
Baxter International
BAX
$13.5B
$229K 0.13%
2,950
+12
+0.4% +$1K
TMO icon
107
Thermo Fisher Scientific
TMO
$213B
$218K 0.13%
+366
New +$210K
SHW icon
108
Sherwin-Williams
SHW
$82.7B
$214K 0.13%
856
+201
+31% +$55.5K
MRK icon
109
Merck
MRK
$322B
$210K 0.12%
+2,577
New +$203K
WFC icon
110
Wells Fargo
WFC
$261B
$209K 0.12%
4,321
+88
+2% +$4.71K
DFAS icon
111
Dimensional US Small Cap ETF
DFAS
$15.4B
$207K 0.12%
3,688
IYW icon
112
iShares US Technology ETF
IYW
$23.6B
$206K 0.12%
2,000
MDT icon
113
Medtronic
MDT
$109B
$204K 0.12%
+1,844
New +$195K
SLYG icon
114
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.07B
$203K 0.12%
2,421
-167
-6% -$14.1K
APEN
115
DELISTED
Apollo Endosurgery, Inc.
APEN
$58K 0.03%
+10,000
New +$60.9K
ONCT
116
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$52K 0.03%
+2,219
New +$80.8K
ICAD
117
DELISTED
iCAD Inc
ICAD
$50K 0.03%
+13,461
New +$67.8K
NEUE
118
DELISTED
NeueHealth
NEUE
$41K 0.02%
263
SRGA
119
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$40K 0.02%
+5,327
New +$81K
BIBL icon
120
Inspire 100 ETF
BIBL
$485M
-5,127
Closed -$202K
CRM icon
121
Salesforce
CRM
$151B
-794
Closed -$202K
FV icon
122
First Trust Dorsey Wright Focus 5 ETF
FV
$3.61B
-4,091
Closed -$201K
MMM icon
123
3M
MMM
$90.9B
-1,499
Closed -$223K
NFLX icon
124
Netflix
NFLX
$299B
-3,420
Closed -$206K
VNQ icon
125
Vanguard Real Estate ETF
VNQ
$39.2B
-19,136
Closed -$2.22M

Similar funds

Waypoint Capital Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Waypoint Capital Advisors held 125 positions worth $170M, up 17% from $146M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Waypoint Capital Advisors deployed $32.3M of net new capital in Q1 2022, opening 28 new positions and adding to 49 existing holdings. Its largest new stake was Alphatec Holdings: 308,247 shares worth $3.74M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $53.1K trimmed.

  • Waypoint Capital Advisors's largest Q1 2022 buy was Alphatec Holdings: 308,247 shares worth $3.74M.
  • Waypoint Capital Advisors added most to Prometheus Biosciences, Inc. Common Stock in Q1 2022, an estimated $3.28M increase.
  • Waypoint Capital Advisors's biggest Q1 2022 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $53.1K.
  • Waypoint Capital Advisors fully exited Vanguard Real Estate ETF in Q1 2022, selling an estimated $2.22M.
  • Waypoint Capital Advisors's ten largest holdings make up 42% of its $170M portfolio in Q1 2022.
  • Waypoint Capital Advisors opened 28 new positions and closed 6 in Q1 2022.
  • Waypoint Capital Advisors's portfolio value rose 17% quarter-over-quarter to $170M.

Based on Waypoint Capital Advisors's 13F filing for Q1 2022, filed 19 Apr 2022.